Literature DB >> 29414782

B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.

Karl L Banta1, Xinyue Wang1, Phani Das1, Astar Winoto2.   

Abstract

Apoptosis is mediated through the extrinsic or intrinsic pathway. Key regulators of the intrinsic apoptotic pathway are the family of B cell lymphoma 2 (Bcl-2) proteins. The activity of the prototypical Bcl-2 protein is usually considered antiapoptotic. However, under some conditions, Bcl-2 associates with the orphan nuclear hormone receptors Nur77 and Nor-1, converting Bcl-2 into a proapoptotic molecule. Expression of Nur77 and Nor-1 is induced by a variety of signals, including those leading to apoptosis. Translocation of Nur77/Nor-1 to mitochondria results in their association with Bcl-2, exposing the Bcl-2 homology (BH) 3 domain and causing apoptosis. However, the molecular details of this interaction are incompletely understood. Here, through extensive Bcl-2 mutagenesis and functional assays, we identified residues within Bcl-2 that are essential for its interaction with Nur77/Nor-1. Although an initial report has suggested that an unstructured loop region between the Bcl-2 BH4 and BH3 domains is required for Bcl-2's interaction with Nur77/Nor-1, we found that it is dispensable for this interaction. Instead, we found important interacting residues at the BH4 domain and crucial interacting residues between the BH1 and BH2 domains. Bcl-2 alanine mutants at this region could no longer interact with Nur77/Nor-1 and could not initiate Nur77/Bcl-2-mediated cell death. However, they still retained their anti-apoptotic capability in two different death assays. These results establish crucial residues in Bcl-2 required for Nur77/Nor-1-mediated apoptosis and point to potential new strategies for manipulating Bcl-2 function.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  B-cell lymphoma 2 (Bcl-2) family; Bcl-b; Nor-1; Nur77; apoptosis; apoptosis regulator; mitochondrial apoptosis; protein-protein interaction; steroid hormone receptor

Mesh:

Substances:

Year:  2018        PMID: 29414782      PMCID: PMC5880130          DOI: 10.1074/jbc.RA117.001101

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  BCL-2 family antagonists for cancer therapy.

Authors:  Guillaume Lessene; Peter E Czabotar; Peter M Colman
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694

Review 2.  Bcl-2-family proteins: the role of the BH3 domain in apoptosis.

Authors:  A Kelekar; C B Thompson
Journal:  Trends Cell Biol       Date:  1998-08       Impact factor: 20.808

3.  Conversion of Bcl-2 to a Bax-like death effector by caspases.

Authors:  E H Cheng; D G Kirsch; R J Clem; R Ravi; M B Kastan; A Bedi; K Ueno; J M Hardwick
Journal:  Science       Date:  1997-12-12       Impact factor: 47.728

4.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

Review 5.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

6.  Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77.

Authors:  Z G Liu; S W Smith; K A McLaughlin; L M Schwartz; B A Osborne
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

Review 7.  Bcl-2-regulated apoptosis: mechanism and therapeutic potential.

Authors:  Jerry M Adams; Suzanne Cory
Journal:  Curr Opin Immunol       Date:  2007-07-12       Impact factor: 7.486

8.  Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.

Authors:  Bingzhen Lin; Siva Kumar Kolluri; Feng Lin; Wen Liu; Young-Hoon Han; Xihua Cao; Marcia I Dawson; John C Reed; Xiao-kun Zhang
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

Review 9.  Bcl-2 inhibitors: small molecules with a big impact on cancer therapy.

Authors:  M Vogler; D Dinsdale; M J S Dyer; G M Cohen
Journal:  Cell Death Differ       Date:  2008-09-19       Impact factor: 15.828

10.  Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells.

Authors:  T Zhou; J Cheng; P Yang; Z Wang; C Liu; X Su; H Bluethmann; J D Mountz
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  8 in total

1.  Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery.

Authors:  Corey Tan; James L Mueller; Mark Noviski; John Huizar; Denise Lau; Alexandra Dubinin; Ari Molofsky; Patrick C Wilson; Julie Zikherman
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

2.  Nur77 promotes cerebral ischemia-reperfusion injury via activating INF2-mediated mitochondrial fragmentation.

Authors:  Hao Zhao; Wenlong Pan; Lihua Chen; Yongchun Luo; Ruxiang Xu
Journal:  J Mol Histol       Date:  2018-10-08       Impact factor: 2.611

Review 3.  Self-reactivity on a spectrum: A sliding scale of peripheral B cell tolerance.

Authors:  Corey Tan; Mark Noviski; John Huizar; Julie Zikherman
Journal:  Immunol Rev       Date:  2019-10-20       Impact factor: 12.988

4.  Cantharidin Induces Apoptosis and Promotes Differentiation of AML Cells Through Nuclear Receptor Nur77-Mediated Signaling Pathway.

Authors:  Zanyang Yu; Li Li; Chengqiang Wang; Hui He; Gen Liu; Haoyue Ma; Lei Pang; Mingdong Jiang; Qianwei Lu; Pan Li; Hongyi Qi
Journal:  Front Pharmacol       Date:  2020-08-28       Impact factor: 5.810

Review 5.  Nuclear Receptors as Regulators of Pituitary Corticotroph Pro-Opiomelanocortin Transcription.

Authors:  Dongyun Zhang; Anthony P Heaney
Journal:  Cells       Date:  2020-04-07       Impact factor: 6.600

Review 6.  Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer.

Authors:  Simona D'Aguanno; Donatella Del Bufalo
Journal:  Cells       Date:  2020-05-21       Impact factor: 6.600

Review 7.  Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death.

Authors:  Jasmine Wyatt; Manuel M Müller; Mahvash Tavassoli
Journal:  Cancers (Basel)       Date:  2019-12-07       Impact factor: 6.639

8.  Ultrasound-Mediated Co-Delivery of miR-34a and sPD-1 Complexed with Microbubbles for Synergistic Cancer Therapy.

Authors:  Yu-E Qin; Wen-Fan Tang; Yun Xu; Fu-Rong Wan; Ai-Hua Chen
Journal:  Cancer Manag Res       Date:  2020-04-05       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.